Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
ADMA BIOLOGICS, INC. roe for the quarter ending 2026-06-30 was 41.39%, a 21.09% decline year-over-year.
ADMA BIOLOGICS, INC. roe for the quarter ending 2026-03-31 was 42.36%, a 23.49% decline year-over-year.
ADMA BIOLOGICS, INC. roe for the quarter ending 2025-12-31 was 30.78%, a 45.65% decline year-over-year.
ADMA BIOLOGICS, INC. roe for the quarter ending 2025-09-30 was 48.57%, a 65.33% increase year-over-year.
ADMA BIOLOGICS, INC. roe for fiscal 2025 was 30.78%, a 45.65% decline from fiscal 2024.
ADMA BIOLOGICS, INC. roe for fiscal 2024 was 56.64%, a change of 77.52% from fiscal 2023.
ADMA BIOLOGICS, INC. roe for fiscal 2023 was -20.89%, a change of 22.48% from fiscal 2022.
ADMA BIOLOGICS, INC. roe for fiscal 2022 was -43.37%, a change of 7.39% from fiscal 2021.